21
Participants
Start Date
June 30, 2011
Primary Completion Date
January 7, 2015
Study Completion Date
February 15, 2017
Pazopanib
800 mg orally once daily for 8 weeks, prior to nephrectomy
North Carolina Cancer Hospital (UNC), Chapel Hill
MD Anderson Cancer Center, Houston
Collaborators (1)
GlaxoSmithKline
INDUSTRY
UNC Lineberger Comprehensive Cancer Center
OTHER